C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151482 Administering to a bird or mammal a PRG-B polypeptide as an angiogenesis inhibitor; antitumor, -carcinogenic, -neoplastic and -arthritic agents; diabetic retinopathy; cancer of the lung, breast, or prostate gland; gene therapy
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151477 Estrogen receptor-related disorders that may be so treated include cancer of the breast and uterus; endometriosis; cardiovascular disorders; menopause; psychological disorders, e.g., antidepressants; anti-inflammatory agents, e.g., asthma
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002	US20020151473 Constrained helical peptides and methods of making same
10/17/2002	US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002	US20020151470 Inhibitors of phospholipase A2
10/17/2002	US20020151469 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151468 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002	US20020151463 Gene and polypeptide compositions in which expression of the agouti gene correlates with the development of insulin independent diabetes, hyperamylinemia, neoplasms and obesity
10/17/2002	US20020151462 Helicobacter pylori membrane proteins
10/17/2002	US20020151461 Modified retinoblastoma tumor supressor proteins
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151457 FRA -1 expression in brain cancer
10/17/2002	US20020151073 Transcription factor
10/17/2002	US20020151071 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
10/17/2002	US20020151064 Regulation of CCR3 expression
10/17/2002	US20020151063 Controlling apoptosis in cells; obtain cells, incubate with modulator, monitor transcriptional activity and apoptosis
10/17/2002	US20020151062 Monitoring efficiency of peptiod to transfect cell; obtain cell, incubate with oligonucleotide and peptiod, monitor efficiency of transfection of oligonucleotide
10/17/2002	US20020151052 Glutamate taste receptor for use in food processing
10/17/2002	US20020151051 Compositions and methods for isolating genes comprising subcellular localization sequences
10/17/2002	US20020151046 52871, a novel human G protein coupled receptor and uses thereof
10/17/2002	US20020151033 Viral vector for use as tool in genetic engineering
10/17/2002	US20020151030 Protein for use in the treatment and prevention of cell proliferative disorders
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151025 Human TSC403 gene and human ING1L gene
10/17/2002	US20020151024 DNA encoding mammalian phosphodiesterases
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151016 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/17/2002	US20020151014 Modified bioluminescent proteins and their use
10/17/2002	US20020151013 Zalpha13: a human secreted protein
10/17/2002	US20020151012 Human endometrial specific steroid-binding factor I, II and III
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020151008 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infections
10/17/2002	US20020151001 Nucleotide sequences coding for the ccpA1 gene
10/17/2002	US20020150999 Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
10/17/2002	US20020150994 Nucleotide sequences coding polypeptide for use in the treatment and prevention of leukemia, tumors, infections, autoimmune, fibrosis, sepsis, allergies and psoriasis
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150992 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
10/17/2002	US20020150991 Polypeptide for use the treatment of glycogen defects
10/17/2002	US20020150990 Hepatitis C virus peptides
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002	US20020150987 Novel molecules of the card-related protein family and uses thereof
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150985 Polypeptide for use in the treatment of cancer
10/17/2002	US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150979 Process for producing a protein
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150975 Peptide for use the treatment of cancer
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150973 Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity
10/17/2002	US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002	US20020150971 Nucleic acids and polypeptides for controlling food intake and/or body weight
10/17/2002	US20020150970 Galectin 8,9,10 and 10sv
10/17/2002	US20020150964 Peptides for the activation of the immune system in humans and animals
10/17/2002	US20020150963 Map
10/17/2002	US20020150958 Detecting modulator of inflammation; obtain enzyme sample, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicate modulator
10/17/2002	US20020150956 Novel tig
10/17/2002	US20020150953 Detecting modulators of muscle protein activity; obtain mixture of calcineurin and muscle protein, monitor binding, incubate with modulator, monitor adjustment in binding activity compare to control
10/17/2002	US20020150946 Mammalian tolloid-like gene and protein
10/17/2002	US20020150924 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of prostate cancer
10/17/2002	US20020150922 Compositions and methods for the therapy and diagnosis of colon cancer
10/17/2002	US20020150920 Novel molecules of the NBS/LRR protein family and uses thereof
10/17/2002	US20020150916 43716, a novel human G-protein and uses thereof
10/17/2002	US20020150914 Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
10/17/2002	US20020150911 T-type calcium channel variants; compositions thereof; and uses
10/17/2002	US20020150908 Diagnosing and detecting cancer in mammals; obtain cells, isolate nucleotide sequences, detect hepsin nucleotide sequences, the presence of hepsin indicates hyperplasia
10/17/2002	US20020150906 Method for determining three-dimensional protein structure from primary protein sequence
10/17/2002	US20020150901 Novel nucleic acids, polypeptides, methods of making, and uses thereof
10/17/2002	US20020150898 Novel nucleic acids and polypeptides
10/17/2002	US20020150897 Method for detecting and isolating genes
10/17/2002	US20020150893 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
10/17/2002	US20020150889 Peptide for use in the detection of herpes virus infections
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150883 Immunoassays for anti-HCV antibodies using antigens with conformational epitopes
10/17/2002	US20020150881 Recovering nucleotide sequences coding preferential protein; obtain phage coding preferential protein, express protein, separate phage displaying binding domain, recover phage displaying chimeric binding protein on surface
10/17/2002	US20020150876 Detecting genetically engineered cells; obtain cells, incubate with nucleic acids, transform, detect expression of preferential genes, expression of genes indicates genetically engineered cells
10/17/2002	US20020150611 Surgical seals; drug delivery; spraying, coagulation
10/17/2002	US20020150595 Antigenic preparations and the isolation of such preparations
10/17/2002	US20020150594 Modulate immunology response
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150590 EBV CTL epitopes
10/17/2002	US20020150589 Administering xenogeneic differentiation antigens
10/17/2002	US20020150588 Hybrid polypeptides; diagnosis, monitoring cancer
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150584 Animal feeds; pneumonia vaccine
10/17/2002	US20020150583 Tumor necrosis factor receptors 6alpha & 6beta
10/17/2002	US20020150581 Compositions and methods for the therapy and diagnosis of breast cancer
10/17/2002	US20020150579 B lymphocyte stimulator (BLyS) as a marker in management of systemic lupus erythematosus

1 ... 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 ... 2916